[{"id":6391,"regimens":[{"id":12374,"duration":{"id":6373,"approximate_duration":null,"dates_unknown":false},"drug":{"id":7230,"name":"Dexamethasone","url":"cure-api2.ncats.io/v1/drugs/7230","rxNorm_id":null,"notes":null},"use_drug":[{"id":9909,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":12374},{"id":9910,"answer":"In a novel combination with another drug","answer_other":"","regimen":12374}],"created":"2020-10-29T19:19:23.564147Z","updated":"2020-10-29T19:48:37.227300Z","dose":"5mg","frequency":"BID","route":"","severity":"ICU/Critical Care","severity_detail":"Intubation and mechanical ventilation, prone positioning","comments":null,"report":6391},{"id":12375,"duration":{"id":6374,"approximate_duration":null,"dates_unknown":false},"drug":{"id":6675,"name":"Ceftriaxone","url":"cure-api2.ncats.io/v1/drugs/6675","rxNorm_id":null,"notes":null},"use_drug":[{"id":9911,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":12375},{"id":9912,"answer":"In a novel combination with another drug","answer_other":"","regimen":12375}],"created":"2020-10-29T19:19:23.571849Z","updated":"2020-10-29T19:48:37.233733Z","dose":"2g","frequency":"Per Day","route":"","severity":"ICU/Critical Care","severity_detail":"Intubation and mechanical ventilation, prone positioning","comments":null,"report":6391},{"id":12376,"duration":{"id":6375,"approximate_duration":null,"dates_unknown":false},"drug":{"id":10399,"name":"Spiramycin","url":"cure-api2.ncats.io/v1/drugs/10399","rxNorm_id":null,"notes":null},"use_drug":[{"id":9913,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":12376},{"id":9914,"answer":"In a novel combination with another drug","answer_other":"","regimen":12376}],"created":"2020-10-29T19:19:23.577865Z","updated":"2020-10-29T19:48:37.239305Z","dose":"1.5 million units","frequency":"q3d","route":"","severity":"ICU/Critical Care","severity_detail":"Intubation and mechanical ventilation, prone positioning","comments":null,"report":6391},{"id":12377,"duration":{"id":6376,"approximate_duration":null,"dates_unknown":false},"drug":{"id":10776,"name":"Tocilizumab","url":"cure-api2.ncats.io/v1/drugs/10776","rxNorm_id":null,"notes":null},"use_drug":[{"id":9915,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":12377},{"id":9916,"answer":"In a novel combination with another drug","answer_other":"","regimen":12377}],"created":"2020-10-29T19:19:23.584087Z","updated":"2020-10-29T19:48:37.245460Z","dose":"8mg/kg","frequency":"Once","route":"IV","severity":"ICU/Critical Care","severity_detail":"Multi organ failure, intubation and mechanical ventilation, prone positioning","comments":null,"report":6391}],"site_of_infection":[],"specific_site":[],"how_outcome":[{"id":8394,"answer":"Clinical assessment","answer_other":"","report":6391}],"how_diagnosis":[{"id":14331,"answer":"Clinical assessment","answer_other":"","report":6391},{"id":14332,"answer":"PCR","answer_other":"","report":6391}],"author_username":"Paige Evans","resistant_drugs":[],"combo_drugs":[],"organisms":[{"id":1887,"name":"Severe acute respiratory syndrome coronavirus 2 (sars-cov-2)"}],"disease_name":"COVID-19","author_qualification":"Nurse","author_affiliation":"None","author_country":"","outcome_computed":"Improved","previous_drugs":[],"comments":[],"article_language":"English","why_new_way":[{"id":4490,"answer":"There is no standard/approved therapy for this disease","answer_other":"","report":6391},{"id":4491,"answer":"Co-Infection or Complex Co-morbidities","answer_other":"","report":6391}],"adverse_event_outcome":[],"is_author":false,"cross_linked_diseases":[],"races":[],"created":"2020-10-29T19:17:28.852274Z","updated":"2020-10-29T19:48:37.219440Z","title":"Tocilizumab for Hemophagocytic Syndrome in a Kidney Transplant Recipient With COVID-19.","status":"Approved","anonymous":false,"published":true,"pubmed_id":32432518,"doi":"10.7326/L20-0419","article_url":"https://pubmed.ncbi.nlm.nih.gov/32432518/","pub_year":2020,"published_authors":"Faguer S\r\nDel Bello A\r\nAbravanel F\r\nNicolau-Travers ML\r\nKamar N","article_author_email":"faguer.s@chu-toulouse.fr.","journal":"Annals of internal medicine","abstract":"To describe a patient with COVID-19 and overt hemophagocytic syndrome whose response to treatment was consistent with this hypothesis.","article_type":"Original","study_type":"Case Report","number_of_patients":1,"article_patient_number":"","full_text_available":true,"outcome":"Patient was cured/recovered","surgery":"No","age":"51-60 years","sex":"Male","ethnicity":null,"country_contracted":"France","country_treated":"France","began_treatment_year":"2020","hiv":false,"asthma":false,"lung_disease":false,"diabetes_mellitus":false,"hypertension":false,"cardiovascular_disease":false,"chronic_renal_disease":true,"chronic_liver_disease":false,"immunosuppressant_drugs":false,"intellectual_disability":false,"smoker":false,"other_immunodeficiency":false,"other_comorbid":"","pregnant":false,"unknown":false,"site_of_disease":"Lungs, heart, kidney","clinical_syndrome":"Multi-organ failure, acute respiratory failure","severity":null,"prev_treatment":"","unusual":"Unusual disease manifestation- hemophagocytic syndrome in a kidney transplant recipient with COVID-19","drug_treatment_features":"","have_adverse_events":false,"adverse_events":"","when_outcome":"While the patient was still on treatment","follow_up_period":null,"relapse":"Unknown","reminder":false,"when_reminder":"1 week","additional_info":"Tocilizumab administration was followed by dramatic improvement of the respiratory, hemodynamic, and liver conditions and correction of the ferritin levels.","previously_treated":"","flagged":false,"other_coinfections":"","disease":630,"drugs":[6675,7230,10399,10776]},{"id":6395,"regimens":[{"id":12383,"duration":{"id":6382,"approximate_duration":null,"dates_unknown":false},"drug":{"id":6653,"name":"Cefotaxime","url":"cure-api2.ncats.io/v1/drugs/6653","rxNorm_id":null,"notes":null},"use_drug":[{"id":9925,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":12383},{"id":9926,"answer":"In a novel combination with another drug","answer_other":"","regimen":12383}],"created":"2020-10-29T20:28:51.360352Z","updated":"2020-10-29T20:35:28.678836Z","dose":"","frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":"","comments":null,"report":6395},{"id":12384,"duration":{"id":6383,"approximate_duration":null,"dates_unknown":false},"drug":{"id":10399,"name":"Spiramycin","url":"cure-api2.ncats.io/v1/drugs/10399","rxNorm_id":null,"notes":null},"use_drug":[{"id":9927,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":12384},{"id":9928,"answer":"In a novel combination with another drug","answer_other":"","regimen":12384}],"created":"2020-10-29T20:28:51.367880Z","updated":"2020-10-29T20:35:28.685149Z","dose":"","frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":"","comments":null,"report":6395},{"id":12385,"duration":{"id":6384,"approximate_duration":null,"dates_unknown":false},"drug":{"id":8342,"name":"Hydroxychloroquine","url":"cure-api2.ncats.io/v1/drugs/8342","rxNorm_id":null,"notes":null},"use_drug":[{"id":9929,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":12385},{"id":9930,"answer":"In a novel combination with another drug","answer_other":"","regimen":12385}],"created":"2020-10-29T20:28:51.374317Z","updated":"2020-10-29T20:35:28.690668Z","dose":"","frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":"","comments":null,"report":6395}],"site_of_infection":[],"specific_site":[],"how_outcome":[{"id":8396,"answer":"Clinical assessment","answer_other":"","report":6395}],"how_diagnosis":[{"id":14341,"answer":"Clinical assessment","answer_other":"","report":6395},{"id":14342,"answer":"Imaging","answer_other":"","report":6395},{"id":14343,"answer":"PCR","answer_other":"","report":6395}],"author_username":"Eleanor McCartney","resistant_drugs":[],"combo_drugs":[],"organisms":[{"id":1887,"name":"Severe acute respiratory syndrome coronavirus 2 (sars-cov-2)"}],"disease_name":"COVID-19","author_qualification":"Medical Doctor","author_affiliation":"None","author_country":"","outcome_computed":"Improved","previous_drugs":[],"comments":[],"article_language":"English","why_new_way":[{"id":4501,"answer":"There is no standard/approved therapy for this disease","answer_other":"","report":6395}],"adverse_event_outcome":[],"is_author":false,"cross_linked_diseases":[{"id":396,"name":"Pneumonia"},{"id":550,"name":"Respiratory Tract Infections"}],"races":[],"created":"2020-10-29T20:27:48.371511Z","updated":"2020-10-29T20:35:28.671115Z","title":"Isolated post SARS-CoV-2 diplopia.","status":"Approved","anonymous":false,"published":true,"pubmed_id":32533321,"doi":"10.1007/s00415-020-09987-x","article_url":"https://pubmed.ncbi.nlm.nih.gov/32533321/","pub_year":2020,"published_authors":"Faucher A\r\nRey PA\r\nAguadisch E\r\nDegos B","article_author_email":"Author email could not be found.","journal":"Journal of neurology","abstract":"No abstract available","article_type":"Original","study_type":"Case Report","number_of_patients":1,"article_patient_number":"1","full_text_available":true,"outcome":"Patient improved","surgery":"No","age":"21-30 years","sex":"Male","ethnicity":null,"country_contracted":"France","country_treated":"France","began_treatment_year":"2020","hiv":false,"asthma":false,"lung_disease":false,"diabetes_mellitus":false,"hypertension":false,"cardiovascular_disease":false,"chronic_renal_disease":false,"chronic_liver_disease":false,"immunosuppressant_drugs":false,"intellectual_disability":false,"smoker":false,"other_immunodeficiency":false,"other_comorbid":"","pregnant":false,"unknown":false,"site_of_disease":"lungs, cranial nerve","clinical_syndrome":"pneumonia, respiratory tract infection, third cranial nerve palsy","severity":null,"prev_treatment":"","unusual":"third cranial nerve palsy","drug_treatment_features":"","have_adverse_events":false,"adverse_events":"","when_outcome":"After a period of follow-up","follow_up_period":"7 days","relapse":"No","reminder":false,"when_reminder":"1 week","additional_info":"This patient received orotracheal intubation and low molecular weight heparin twice per day. This patient recovered in hospital 7 14 days after diagnosis, however they returned the day after discharge with binocular horizontal diplopia from which they rapidly recovered after 7 days. It is suspected that this was a case of SARS-Cov-2-related third cranial nerve palsy.","previously_treated":"","flagged":false,"other_coinfections":"","disease":630,"drugs":[6653,8342,10399]},{"id":6466,"regimens":[{"id":12628,"duration":{"id":6620,"approximate_duration":null,"dates_unknown":false},"drug":{"id":10399,"name":"Spiramycin","url":"cure-api2.ncats.io/v1/drugs/10399","rxNorm_id":null,"notes":null},"use_drug":[{"id":10477,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":12628},{"id":10478,"answer":"In a novel combination with another drug","answer_other":"","regimen":12628}],"created":"2020-11-16T14:45:13.376116Z","updated":"2020-11-17T15:32:22.279679Z","dose":"","frequency":"","route":"","severity":"Inpatient","severity_detail":"","comments":null,"report":6466},{"id":12629,"duration":{"id":6621,"approximate_duration":"3 days","dates_unknown":true},"drug":{"id":5848,"name":"Amikacin","url":"cure-api2.ncats.io/v1/drugs/5848","rxNorm_id":null,"notes":null},"use_drug":[{"id":10479,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":12629},{"id":10480,"answer":"In a novel combination with another drug","answer_other":"","regimen":12629}],"created":"2020-11-16T14:45:13.383793Z","updated":"2020-11-17T15:32:22.286064Z","dose":"","frequency":"","route":"","severity":"Inpatient","severity_detail":"","comments":null,"report":6466},{"id":12630,"duration":{"id":6622,"approximate_duration":null,"dates_unknown":false},"drug":{"id":6675,"name":"Ceftriaxone","url":"cure-api2.ncats.io/v1/drugs/6675","rxNorm_id":null,"notes":null},"use_drug":[{"id":10481,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":12630},{"id":10482,"answer":"In a novel combination with another drug","answer_other":"","regimen":12630}],"created":"2020-11-16T14:45:13.390471Z","updated":"2020-11-17T15:32:22.291419Z","dose":"","frequency":"","route":"","severity":"Inpatient","severity_detail":"","comments":null,"report":6466}],"site_of_infection":[],"specific_site":[],"how_outcome":[],"how_diagnosis":[{"id":14531,"answer":"Clinical assessment","answer_other":"","report":6466},{"id":14532,"answer":"Imaging","answer_other":"","report":6466},{"id":14593,"answer":"PCR","answer_other":"","report":6466}],"author_username":"Cure Admin","resistant_drugs":[],"combo_drugs":[],"organisms":[{"id":1887,"name":"Severe acute respiratory syndrome coronavirus 2 (sars-cov-2)"}],"disease_name":"COVID-19","author_qualification":"Other Healthcare Professional","author_affiliation":"FDA/NCATS","author_country":"United States","outcome_computed":"Deteriorated","previous_drugs":[],"comments":[],"article_language":"English","why_new_way":[{"id":4604,"answer":"There is no standard/approved therapy for this disease","answer_other":"","report":6466}],"adverse_event_outcome":[],"is_author":false,"cross_linked_diseases":[{"id":396,"name":"Pneumonia"},{"id":550,"name":"Respiratory Tract Infections"}],"races":[],"created":"2020-11-16T14:44:28.430740Z","updated":"2020-11-17T15:32:22.271699Z","title":"Pay more attention to EEG in COVID-19 pandemic.","status":"Approved","anonymous":false,"published":true,"pubmed_id":32482439,"doi":"10.1016/j.clinph.2020.05.011","article_url":"https://pubmed.ncbi.nlm.nih.gov/32482439/","pub_year":2020,"published_authors":"Flamand M\r\nPerron A\r\nBuron Y\r\nSzurhaj W","article_author_email":"Author email could not be found.","journal":"Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology","abstract":"No abstract available","article_type":"Original","study_type":"Case Report","number_of_patients":1,"article_patient_number":"1","full_text_available":true,"outcome":"Patient died","surgery":"No","age":"71-80 years","sex":"Female","ethnicity":null,"country_contracted":"France","country_treated":"France","began_treatment_year":"2020","hiv":false,"asthma":false,"lung_disease":false,"diabetes_mellitus":false,"hypertension":false,"cardiovascular_disease":false,"chronic_renal_disease":false,"chronic_liver_disease":false,"immunosuppressant_drugs":false,"intellectual_disability":false,"smoker":false,"other_immunodeficiency":false,"other_comorbid":"","pregnant":false,"unknown":false,"site_of_disease":"lungs, brain","clinical_syndrome":"pneumonia, respiratory tract infection, altered consciousness, focal motor seizures","severity":"ICU/Critical Care","prev_treatment":"","unusual":"","drug_treatment_features":"","have_adverse_events":false,"adverse_events":"","when_outcome":"At the time the treatment was completed","follow_up_period":null,"relapse":"No","reminder":false,"when_reminder":"1 week","additional_info":"This patient experienced focal motor seizures and altered consciousness, MRI and cerebrospinal fluid analysis was unremarkable. This patient also had EEGs that showed paroxysms with a triphasic aspect suggesting a toxic/metabolic encephalopathy. The patient died on their 25th day after admission.","previously_treated":"","flagged":false,"other_coinfections":"","disease":630,"drugs":[5848,6675,10399]}]